Functional genomics technology has brought numerous advances to cancer biology and to the discovery of new therapeutic targets. Now, collaborative research that was carried out with many colleagues across the country…
Read More
While some human cancers occur as a result of age-dependent accumulation of genetic mutations, and others are caused by deficiencies in DNA replication or repair, the causes of many oncogenic…
Read MoreTo enable quantitative analysis of post-translational protein modifications, Paolo Cifani and Mojdeh Shakiba in the lab developed ProteoModlR, a R program for quantitative analysis of relative and absolute abundance and…
Read MoreWelcome to the course page for Next-Gen Methods in Pharmacology! Graduate Program in Pharmacology, Weill Cornell Medical College and Sloan Kettering Institute Course Directors: Michael Kharas & Alex Kentsis This…
Read MoreTransposons are mobile genetic elements that are found in most living organisms. We have now found that human PGBD5 can induce DNA transposition in human cells. The apparent conservation of…
Read MoreOutstanding talk by Dr. Alex Kentsis @KentsisResearch describing his work using novel genomic and proteomic approaches for cancer therapy, including #leukemia #leusm @sloan_kettering @WeillCornell
2Improved protein structure prediction using potentials from deep learning https://t.co/o7KdQywMn1
@JaroszLab : A Non-amyloid Prion Particle that Activates a Heritable Gene Expression Program https://t.co/JwLBU3TaDA
Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation https://t.co/A8lyzHSshY
